Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jenkins, Kimberly A
NCT05553145: The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care	Completed	N/A	200	US	Autoimmune Antibody Assays	The Cleveland Clinic	Type 2 Diabetes	05/23	08/24
ARR, NCT05757076: Aldosterone Renin Ratio () Test to Increase Case-detection of Primary Aldosteronism (PA)	Recruiting	N/A	50	US	Blood test for ARR	The Cleveland Clinic	Primary Aldosteronism	03/25	08/25
NCT06407024: Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy	Recruiting	N/A	54	US	laparoscopic transabdominal adrenalectomy, robotic transabdominal adrenalectomy	The Cleveland Clinic	Adrenalectomy	12/25	08/26
DexcomG7, NCT06338748: Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery	Recruiting	N/A	28	US	Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode	The Cleveland Clinic, DexCom, Inc.	Continuous Glucose Monitoring	07/25	12/25
DKA, NCT06471322: A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients with Type 1 Diabetes	Recruiting	N/A	12	US	Continuous Glucose Monitoring (CGM), Standard of Care	The Cleveland Clinic	Diabetic Ketoacidosis	10/25	12/26
NCT05761743: Glycemic Control, Type II Diabetes, Parathyroidectomy	Recruiting	N/A	80	US	Urine and Blood Test	The Cleveland Clinic	Primary Hyperparathyroidism, Type 2 Diabetes	07/25	02/26
Pantalone, Kevin
TRANSITION-T2D, NCT04538352: Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D	Completed	4	60	US	Semaglutide, Ozempic, Insulin Degludec, Tresiba, Insulin aspart, Novolog	The Cleveland Clinic, Novo Nordisk A/S	Type 2 Diabetes	03/23	11/23
NCT05553145: The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care	Completed	N/A	200	US	Autoimmune Antibody Assays	The Cleveland Clinic	Type 2 Diabetes	05/23	08/24
NCT05181449: Randomized Controlled Trial of Digital Twin Precision Treatment: A Novel Whole Body Digital Twin Enabled Precision Treatment for Type 2 Diabetes	Active, not recruiting	N/A	150	US	Twin Precision Treatment	The Cleveland Clinic, Twin Health	Type 2 Diabetes	05/25	07/25